---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-182802"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2022-06-27T23:59:59+00:00"
generated_at: "2026-06-24T23:01:04.661402+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aligos Therapeutics reports annual meeting vote results; directors elected, auditor ratified

## Summary
- Elected Class II directors: Thomas Woiwode (21.3M for, 4.2M withheld), Leonid Beigelman (21.5M for, 4.0M withheld), K. Peter Hirth (21.9M for, 3.6M withheld).
- Ratification of Ernst & Young as auditor for FY2022 passed with 29.5M for, 90k against, 125 abstentions.
- Broker non-votes of ~4.0M shares on director election.

## SEC filing metadata
- accession: 0001193125-22-182802
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2022-06-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312522182802/0001193125-22-182802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312522182802/d356477d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-182802
- JSON: https://secwatch.observer/filing/0001193125-22-182802.json
- Plain text: https://secwatch.observer/filing/0001193125-22-182802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.